"Obesity Paradox" in chronic obstructive pulmonary disease

Israel Medical Association Journal

Volumn 13, Issue 11, 2011, Pages 672-675

  Blum, Arnon ^a,c   Simsolo, Claudia ^a   Sirchan, Rizak ^a   Haiek, Samah ^b  

^a Poriya Hospital   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

^c MIAMI UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease; Obesity; Peripheral artery disease

Indexed keywords

ABDOMINAL CIRCUMFERENCE; ACUTE HEART INFARCTION; AGED; ANKLE BRACHIAL INDEX; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG EMBOLISM; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY;

AGED; ATHEROSCLEROSIS; BODY MASS INDEX; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OBESITY; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 80755176729     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Respir Crit Care Med 2007; 176: 532-55.
2. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5 year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-9.
3. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775-89.
4. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-61.
5. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173: 79-83.
6. Thorand B, Baumert J, Doring A, et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006; 184: 216-24.
7. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-5.
8. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: crosssectional study. Atherosclerosis 2004; 172 (1): 95-105.
9. Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120 (21): 2053-61.
10. Van Kuijk JP, Flu WJ, Hoeks SE, et al. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. Eur Heart J 2010; 31 (8): 992-9.
11. Moro L, Pedone C, Scarlata S, Malafarina V, Fimognari F, Antonelli-Incalzi R. Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology 2008; 59 (3): 357-64.
12. Carter SA. The role of pressure measurements in vascular disease. In: Bernstein EF, ed. Non Invasive Diagnostic Techniques in Vascular Disease. St. Louis: Mosby, 1985: 513-44.
13. Curb JD, Masaki K, Rodriguez BL, et al. Peripheral artery disease and cardiovascular risk factors in the elderly: the Honolulu Heart Program. Arterioscler Thromb Vasc Biol 1996; 16: 1495-500.
14. Murabito JM, Evans JC, Nieto K, et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002; 143: 961-5.
15. Vogt MT, McKenna M, Anderson SJ, et al. The relationship between ankle-arm index and mortality in older men and women. J Am Geriatr Soc 1993; 41: 523-30.
16. Newman AB, Tyrrell KS, Kuller LH. Mortality over four years in SHEP participants with a low ankle-arm index. J Am Geriatr Soc 1997; 45: 1472-8.
17. Leng GC, Fowkes FG, Lee AJ, et al. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996; 313: 1440-4.
18. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality-the Strong Heart Study. Circulation 2004; 109: 733-9.
19. Galal W, van Domburg RT, Feringa HH, et al. Relation of body mass index to outcome in patients with known or suspected coronary artery disease. Am J Cardiol 2007; 99: 1485-90.
20. Uretsky S, Messerli FH, Bangalore S, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007; 120: 863-70.
21. Galal W, van Gestel Y, Hoeks SE, et al. The obesity paradox in patients with peripheral arterial disease. Chest 2008; 134: 925-30.